Skip to main content
. 2021 Jun 2;26(11):3348. doi: 10.3390/molecules26113348

Table 3.

Pharmacological agents which have potential effects on RTT treatment.

Names Structures Targets Effects
F15599 graphic file with name molecules-26-03348-i013.jpg 5-HT1AR agonist normalization of respiratory function [93]
sarizotan graphic file with name molecules-26-03348-i014.jpg 5-HT1AR agonist, affinity to D2R/D3R/D4R normalization of respiratory function [66,95]